To this end, we used bioinformatics to explore the upstream transcription factors of HAS2-AS1, and found that the expression of USF1 in the tumor group was significantly up-regulated and positively correlated with the expression of HAS2-AS1. The gene discussed is USF1; the disease is neoplasm.